Morphologic, Functional, and Metabolic Magnetic Resonance Imaging-Guided Prostate Biopsy in a Patient with Prior Negative Transrectal Ultrasound-Guided Biopsies and Persistently Elevated Prostate-Specific Antigen Levels

Urology

Volumn 69, Issue 6, 2007, Pages 1208.e5-1208.e8

  Lichy, Matthias P ^a   Anastasiadis, Aristotelis G ^a   Aschoff, Philip ^a   Sotlar, Karl ^a   Eschmann, Susanne M ^a   Pfannenberg, Christina ^a   Stenzl, Arnulf ^a   Claussen, Claus D ^a   Schlemmer, Heinz Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; IOPROMIDE; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER LOCALIZATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLEASON SCORE; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSRECTAL ULTRASONOGRAPHY;

EID: 34250003210     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.009     Document Type: Article

References (13)

1. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324 (1991) 1156-1161
2. Djavan B., Milani S., and Remzi M. Prostate biopsy: who, how, and when. An update. Can J Urol 12 suppl 1 (2005) 44-48
3. Lujan M., Paez A., Santonja C., et al. Prostate cancer detection and tumor characteristics in men with multiple biopsy sessions. Prostate Cancer Prostatic Dis 7 (2004) 238-242
4. Prando A., Kurhanewicz J., Borges A.P., et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236 (2005) 903-910
5. Kurhanewicz J., Vigneron D.B., Nelson S.J., et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 45 (1995) 459-466
6. Sandblom G., Sorensen J., Lundin N., et al. Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy. Urology 67 (2006) 996-1000
7. Sutinen E., Nurmi M., Roivainen A., et al. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging 31 (2004) 317-324
8. Scher B., Seitz M., Albinger W., et al. Value of (11)C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging 34 (2007) 45-53
9. Breeuwsma A.J., Pruim J., Jongen M.M., et al. In vivo uptake of [11C] choline does not correlate with cell proliferation in human prostate cancer. Eur J Nucl Med Mol Imaging 32 (2005) 668-673
10. Martorana G., Schiavina R., Corti B., et al. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. J Urol 176 (2006) 954-960
11. Anastasiadis A.G., Lichy M.P., Nagele U., et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50 (2006) 738-749
12. Engelhard K., Hollenbach H.P., Kiefer B., et al. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol 16 (2006) 1237-1243
13. Sato C., Naganawa S., Nakamura T., et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21 (2005) 258-262